Burkina Faso vs Kazakhstan: Number of clinical trials
Burkina Faso
13
in 2024
Kazakhstan
13
in 2024
Burkina Faso rank
63rd
Kazakhstan rank
63rd
Number of clinical trials over time
- Burkina Faso
- Kazakhstan
How they compare
Burkina Faso currently reports 13 against 13 in Kazakhstan, a difference of 0.
The two have swapped places 5 times across 16 shared years of data; in 2005 it was Burkina Faso ahead.
Burkina Faso ranks 63rd and Kazakhstan ranks 63rd of 153 countries.
Across the 3 decades both report, Burkina Faso averaged higher in 2 and Kazakhstan in 1.
Head to head by decade
| Decade | Burkina Faso | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2 | 1 | 1 | Burkina Faso |
| 2010s | 6.3 | 2.5 | 3.8 | Burkina Faso |
| 2020s | 9.6 | 13.4 | 3.8 | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of clinical trials, Burkina Faso or Kazakhstan?
- Burkina Faso, at 13 against 13 in Kazakhstan as of 2024.
- What is the difference in number of clinical trials between Burkina Faso and Kazakhstan?
- 0, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Kazakhstan?
- 16 years are reported by both, from 2005 to 2024.
- How do Burkina Faso and Kazakhstan rank globally for number of clinical trials?
- Burkina Faso ranks 63rd and Kazakhstan ranks 63rd of 153 countries.
- Where does this data come from?
- Our World in Data, published as Number of clinical trials. Statizoid refreshes it automatically from the source and publishes the full history for both places.